Search Results 2011-2020 of 16959 for ozempic
About this study. This randomized phase II trial is for medically inoperable early stage non-small cell lung cancer (NSCLC) patients.
As scientists at the Mayo Clinic Center for Individualized Medicine discover new ways to use genomic information in the diagnosis, treatment and prevention of ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
ROCHESTER, Minn. — Mayo Clinic scientists have developed an immunotherapy strategy that potentially lays the groundwork for treating a spectrum of autoimmune ...
This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that ...
To conduct research on RBD as a prodromal manifestation of DLB, PD, and MSA to address several of the NAPA ADRD priorities for LBD research as well as similar ...
The primary purpose of this study is to is to develop an advanced multiparametric liver magnetic resonance elastography (MRE) imaging technology for early ...
About this study. VICTORY AF is an IDE, prospective global, multi-center, single arm, controlled, unblinded, investigational clinical study.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.